---
id: endocrine-society-hyponatremia-2024
title: "Endocrine Society 2024 Clinical Practice Guideline: Diagnosis and Treatment of Hyponatremia"
short_title: "ES Hyponatremia 2024"

organization: Endocrine Society
collaborators: null
country: US
url: https://www.endocrine.org/guidelines
doi: null
pmid: null
open_access: true

specialty: endocrinology
guideline_type: clinical-practice
evidence_system: Endocrine Society GRADE
conditions:
  - hyponatremia
  - SIADH
  - sodium disorders
tags:
  - fluid restriction
  - hypertonic saline
  - tolvaptan
  - osmotic demyelination
  - urine osmolality

publication_date: 2024-04-01
previous_version_date: 2014-02-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-26
---

## Scope
2024 Endocrine Society guideline update on the diagnosis and treatment of hyponatremia in adults and children.

## Key Recommendations

### Definition
- Hyponatremia: Serum sodium <135 mEq/L.
- Mild (130-135), Moderate (125-129), Severe (<125).

### Diagnostic Evaluation
1. **Serum Osmolality**: Rule out pseudohyponatremia (high lipids/proteins) or translocational (hyperglycemia).
2. **Urine Osmolality**: >100 mOsm/kg suggests impaired water excretion (e.g., SIADH).
3. **Urine Sodium**: >30 mEq/L in euvolemic/hypervolemic hyponatremia with high urine osm = SIADH, adrenal insufficiency, or diuretic use.
4. **Volume Status Assessment**: Hypovolemic, euvolemic, hypervolemic.

### Causes
- **Hypovolemic**: GI losses, renal losses (diuretics).
- **Euvolemic**: SIADH (most common), hypothyroidism, adrenal insufficiency.
- **Hypervolemic**: Heart failure, cirrhosis, nephrotic syndrome.

### Treatment

#### Symptomatic Severe Hyponatremia (Seizures, Altered Mental Status)
- **Hypertonic Saline (3% NaCl)**: 100-150 mL bolus; target 4-6 mEq/L increase in sodium over first 1-2 hours.
- Limit total correction to <8-10 mEq/L in 24 hours to prevent osmotic demyelination syndrome (ODS).

#### Chronic / Asymptomatic Hyponatremia
- **Treat Underlying Cause**.
- **SIADH**:
  - Fluid restriction (~1-1.5 L/day).
  - Salt tablets Â± loop diuretic (to increase free water excretion).
  - **Vaptans (Tolvaptan)**: Oral V2 receptor antagonist. Effective for SIADH; monitor sodium closely; avoid in hypovolemia or liver disease.
  - Urea: Alternative to increase solute load.

### Monitoring
- Frequent sodium checks (every 2-4 hours) during acute correction.
- Avoid rapid overcorrection.
